Biomab Egfr 50 mg Injection 1's
MRP ₹61541
(Inclusive of all Taxes)
₹7385.0 Cashback (12%)
Know Your Delivery Time
Provide Delivery Location
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Composition :
Manufacturer/Marketer :
Consume Type :
Expires on or after :
Return Policy :
About Biomab Egfr 50 mg Injection
Biomab Egfr 50 mg Injection belongs to the group of anti-cancer medicines used to treat head and neck cancer with concurrent chemotherapy and/or radiotherapy. It may also be indicated in the treatment of glioma (growth of tumours in the brain or spinal cord) and nasopharyngeal cancer.
Biomab Egfr 50 mg Injection contains Nimotuzumab, a recombinant humanised monoclonal antibody that works by binding to receptors on cancer cells and prevents them from destroying the body’s immune system. Thereby, it helps treat cancer.
In some cases, Biomab Egfr 50 mg Injection may cause side effects like fever, chills, headache, itching, and mucositis. Most of these side effects may not require medical attention and resolve gradually over time. Do not be reluctant to talk with your doctor if any of the side effects persist or worsen.
Do not use Biomab Egfr 50 mg Injection if you are allergic to any of its components. Consult the doctor if you are pregnant or breastfeeding. Keep the doctor informed about your health condition and medications to rule out any side effects/interactions.
Uses of Biomab Egfr 50 mg Injection
Biomab Egfr 50 mg Injection is used in the treatment of Head and neck cancer. The detailed use of Biomab Egfr 50 mg Injection is as follows:
- Head and neck cancers: Biomab Egfr 50 mg Injection is used in the treatment of head and neck cancers especially squamous cell carcinomas.
Have a query?
Directions for Use
- Follow your doctor's instructions on the dosage and timing of this medication.
- Biomab Egfr 50 mg Injection is administered by the doctor or nurse.
- Do not self-administer.
Key Benefits
Biomab Egfr 50 mg Injection belongs to the group of anti-cancer medicines used to treat head and neck cancer with concurrent chemotherapy and/or radiotherapy. Biomab Egfr 50 mg Injection contains Nimotuzumab, a recombinant humanised monoclonal antibody that works by binding to receptors on cancer cells and prevents them from destroying the body’s immune system. Thereby, it helps treat cancer. Nimotuzumab may also be indicated in the treatment of glioma (growth of tumours in the brain or spinal cord) and nasopharyngeal cancer.
How Biomab Egfr 50 mg Injection Works
Storage
What if I have taken an overdose of Biomab Egfr 50 mg Injection
Drug Warnings
Do not use Biomab Egfr 50 mg Injection if you are allergic to any of its components. Inform the doctor if you are pregnant or breastfeeding. Please consult the doctor if you have any concerns regarding the usage of Biomab Egfr 50 mg Injection in children. Let the doctor know if you have any health conditions or if you are taking any medications, including herbal supplements.
Diet & Lifestyle Advise
- Eat a healthy diet and exercise regularly to maintain proper weight.
- Avoid smoking and alcohol consumption.
- Include vegetables and fruits in your diet.
- Avoid fast food, fried food, processed meats, refined carbs and added sugar.
- Get optimal sleep; rest well.
Habit Forming
Therapeutic Class
Alcohol
Consult your doctor
It is not known if alcohol affects Biomab Egfr 50 mg Injection. Please consult the doctor.
Pregnancy
Caution
Consult the doctor if you are pregnant. It should be used during pregnancy only if the benefits outweigh the risks.
Breast Feeding
Caution
It is not known if this medicine passes into breast milk. Consult the doctor if you are breastfeeding.
Driving
Consult your doctor
It is unknown if Biomab Egfr 50 mg Injection affects your ability to drive. Drive only if you are alert.
Liver
Consult your doctor
If you have a history of liver problems, inform the doctor before receiving Biomab Egfr 50 mg Injection.
Kidney
Consult your doctor
If you have a history of kidney problems, inform the doctor before receiving Biomab Egfr 50 mg Injection.
Children
Caution
Please consult the doctor if you have any concerns regarding the usage of Biomab Egfr 50 mg Injection in children.
Heart
Please consult your doctor before receiving Biomab Egfr 50 mg Injection if you have pre-existing heart problems. Your doctor will prescribe Biomab Egfr 50 mg Injection if the benefits outweigh the risks.
Geriatrics
Safe if prescribed
Biomab Egfr 50 mg Injection is generally considered safe when used under medical supervision in geriatric patients. However, please consult your doctor if you have any concerns.
FAQs
Biomab Egfr 50 mg Injection is used to treat Head and neck cancer.
Biomab Egfr 50 mg Injection works by binding to receptors on cancer cells and prevents them from destroying the body’s immune system. Thereby, it helps treat cancer.
Biomab Egfr 50 mg Injection may cause hypertension (high blood pressure) and fluctuation in blood pressure. Consult the doctor if you have high blood pressure or if you experience fluctuation in blood pressure.
Mucositis (swelling and irritation of mucosa) could be a side effect of Biomab Egfr 50 mg Injection. If the condition persists or worsens, consult the doctor.
Country of origin
Manufacturer/Marketer address
Disclaimer
Keep Refrigerated. Do not freeze.Prepaid payment required.
Author Details
